1.5 Abstract in rivista
 Distribuzione geografica
Continente #
AS - Asia 17.150
NA - Nord America 3.894
EU - Europa 1.798
SA - Sud America 1.007
AF - Africa 116
OC - Oceania 73
Totale 24.038
Nazione #
SG - Singapore 12.874
US - Stati Uniti d'America 3.675
CN - Cina 1.904
HK - Hong Kong 1.249
BR - Brasile 768
GB - Regno Unito 557
VN - Vietnam 475
IT - Italia 454
IN - India 225
DE - Germania 221
CA - Canada 135
AR - Argentina 112
NL - Olanda 94
ID - Indonesia 76
AU - Australia 62
TR - Turchia 62
MX - Messico 61
FI - Finlandia 56
EE - Estonia 54
CZ - Repubblica Ceca 52
EC - Ecuador 43
PL - Polonia 42
JP - Giappone 41
FR - Francia 40
UA - Ucraina 39
PK - Pakistan 34
ZA - Sudafrica 34
BD - Bangladesh 33
ES - Italia 32
EG - Egitto 23
CL - Cile 20
CO - Colombia 20
PY - Paraguay 20
TW - Taiwan 20
AE - Emirati Arabi Uniti 18
MY - Malesia 18
SE - Svezia 18
RU - Federazione Russa 17
AT - Austria 14
IE - Irlanda 14
PH - Filippine 14
SA - Arabia Saudita 11
TH - Thailandia 11
ET - Etiopia 10
VE - Venezuela 10
DK - Danimarca 9
IQ - Iraq 9
KZ - Kazakistan 9
LT - Lituania 9
AZ - Azerbaigian 8
CH - Svizzera 8
UY - Uruguay 8
HU - Ungheria 7
IL - Israele 7
KR - Corea 7
KW - Kuwait 7
NP - Nepal 7
BE - Belgio 6
IR - Iran 6
NG - Nigeria 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
RO - Romania 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
MA - Marocco 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
GH - Ghana 4
GR - Grecia 4
JM - Giamaica 4
OM - Oman 4
SI - Slovenia 4
AO - Angola 3
BO - Bolivia 3
HN - Honduras 3
KE - Kenya 3
LK - Sri Lanka 3
MD - Moldavia 3
MK - Macedonia 3
PE - Perù 3
PS - Palestinian Territory 3
RS - Serbia 3
AD - Andorra 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CU - Cuba 2
GN - Guinea 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
LY - Libia 2
PG - Papua Nuova Guinea 2
SD - Sudan 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 24.001
Città #
Singapore 1.390
Hong Kong 1.226
Hefei 986
Ashburn 945
Dallas 660
Boardman 581
London 457
Shanghai 341
Beijing 338
Ho Chi Minh City 187
Council Bluffs 184
Los Angeles 149
San Francisco 120
Pune 111
Rome 106
Hanoi 105
West Jordan 90
São Paulo 83
Munich 70
Amsterdam 64
Washington 59
Toronto 57
Santa Clara 46
Seattle 46
Milan 44
New York 42
Brno 40
Warsaw 37
Brooklyn 36
Sona 36
Chicago 35
Turku 35
Mexico City 31
Montreal 28
Tokyo 26
Rio de Janeiro 25
Haiphong 24
Helsinki 21
Melbourne 21
Chennai 19
Canberra 18
Hanover 18
Da Nang 17
Boston 16
Brasília 16
Jakarta 16
Quito 16
Buenos Aires 15
Guayaquil 15
Stockholm 15
Thái Bình 15
Johannesburg 14
Paris 14
Central 13
Hải Dương 13
Kuala Lumpur 13
Naples 13
Porto Alegre 13
San Jose 13
Biên Hòa 12
Charlotte 12
Manchester 12
Ankara 11
Bangkok 11
Curitiba 11
New Delhi 11
Ninh Bình 11
Riyadh 11
Sydney 11
Belo Horizonte 10
Glasgow 10
Olomouc 10
Phoenix 10
Secaucus 10
Çankaya 10
Atlanta 9
Berlin 9
Cairo 9
Dublin 9
Istanbul 9
Vienna 9
Andover 8
Buffalo 8
Copenhagen 8
Nuremberg 8
Addis Ababa 7
Brescia 7
Catania 7
Hortolândia 7
Manaus 7
Manila 7
Oklahoma City 7
Redmond 7
Vancouver 7
Arlington 6
Auckland 6
Baku 6
Bengaluru 6
Bologna 6
Calgary 6
Totale 9.542
Nome #
PLASTIC IN PLACENTA: WHAT IS IT? WHAT TO DO? 330
18F-Choline PET/CT for early detection of prostate cancer recurrence after radical prostatectomy 297
1338P TP53 truncating and missense mutations are linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer (NSCLC) 281
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 254
112P Measuring time-toxicity and prognostic impact of hospital attendance in early phase cancer trials participants 249
1352P Real-world second-line outcomes of NSCLC patients receiving first-line chemotherapy plus immunotherapy 246
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 232
Effect of hypothermia on human colonic smooth muscle contractility 213
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 213
1-year results of the subclavian access for tavi with the corevalve bioprosthesis in 132 consecutive patients 212
A new adjunct for emergency airway management:the Laryngeal Tube, preliminary data 211
69P Dose-dependent detrimental effect of proton pump inhibitors (PPIs) on clinical outcomes from immune checkpoint inhibitors (ICI) in patients (pts) with solid tumors 210
Purse-String Closure vs Conventional Direct Closure of Wounds after Stoma Reversal: A Prospective Randomized Controlled Study 209
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 203
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 201
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 200
A biomechanical index for the evaluation of upper arm motor control in a subject affected by polyradiculoneuropathy 200
602 Frequent Epigenetic Inactivation of KEAP1 Gene in Breast Cancer 197
P3.13C.09 First-Line Treatments for Advanced Pure Large Cell Neuroendocrine Tumors (LCNEC):Insights from a Global Clinico-Genomic Study 196
Disclosing 3D Shape of Ossa Genitalia in Primates 193
Adipokines: The Missing Link between Alzheimer's Disease and Type 2 Diabetes? 191
Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single centre retrospective analysis 190
18F-CHOLINE PET/CT FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY 190
Postoperative Serum Procalcitonin to Predict Clinically Relevant Pancreatic Fistula after Pancreatoduodenectomy 190
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 188
Does HE4 have a role in the recurrence of ovarian cancer? 188
Chronotherapy and surgery for unresectable hepatic metastases from colorectal cancer 188
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 187
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 185
Aligned electrospun poly-l-lactide fibers for tendon regeneration: a preliminary in vitro study 185
Risultati preliminari dell’uso della risonanza magnetica nello studio dei disturbi dell’evacuazione 184
Assessment of liver function by the exhaled breath-print during chronic liver disease 182
Gait Speed Is a Valid Indicator in the Assessment of Perioperative Risk in the Elderly Surgical Patient 181
Diagnosis of labour: the II prospective clinical study 180
APPLICATION OF RADIOFREQUENCY INTERSTITIAL TUMOR ABLATION(RITA) IN "NO CLAMP-NO SUTURE" LAPAROSCOPIC PARTIAL NEPHRECTOMY 180
EP24.13: Fetomaternal hemorrhage: a new hypothesis on the importance of fetal vasoconstriction – a case report 178
3D Bioprinting of Human Skin and Squamous Cell Tumors (SCCs) as Advanced Models for Precision Medicine (BIOSQIN) 176
Biomimetic Polyurethane Scaffolds Guiding the In Vitro Behavior of Cardiac Stem Cells 170
CARBOPLATINUM IN NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER: A PILOT STUDY. 170
Hepatic Artery Anomaly Does Not Impact Pancreatoduodenectomy Outcomes: A Matched Pair Analysis 168
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 165
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 163
The Hendrich II model for assessing the risk of falls for hospitalized patients [Il modello Hendrich II per la valutazione del rischio di cadute per pazienti ospedalizzati] 147
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 138
18F-CHOLINE PET/CT FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY. 128
Cerebral Hemodynamics, Patent foramen ovale and White Matter Hyperintensities in patients Migraine with aura, young stroke patients and controls 124
Abruptio placenta and TLRs 2-3-4 123
35. Association of robot-assisted rehabilitation and non-invasive brain stimulation to improve upper limb function in chronic stroke patients 114
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 113
EBUS-TBNA, EUS-FNA or EUS-B-FNA for mediastinal staging of lung cancer: A purpose of diagnostic algorithm 113
GH-resistance in different stages of chronic liver disease 111
534 Determinants of 5-year survival in patients with advanced NSCLC with PD-L1 ≥50% treated with first line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry 110
A polysaccharide foam-like scaffold obtained by crosslinking lactose-modified chitosan and oxidized hyaluronan 110
A case of synchronous hepatic and gastric malignancies: diagnostic problems and therapeutical strategies 110
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 109
485 Impact of opioid signaling on the tumor microenvironment and clinical outcomes in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) 104
Assessment of renal damage following warm ischemia time during LPN: results of a prospective study 103
Biological effects of cabozantinib on bone microenvironment 103
The ability of Lung High-Resolution Computed Tomography Severity Score to early identify COVID-19 patients who need respiratory support. A retrospective analysis of a monocentric Italian COVID-19 cohort 101
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 100
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 100
"NO CLAMP NO SUTURE'' LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR SMALL EXOPHYTIC RENAL TUMORS 99
THU-464 aMAP score predicts progression-free survival in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma 99
A meta-synthesis of experiences of caregivers of people with COPD. 98
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 97
Amniotic membrane transplantation associated with conjunctival peritomy in the management of Mooren's ulcer. 96
Chemokines and Inflammatory Mediators in Erosive Esophagitis (EE) Compared to Non-Erosive Reflux Disease (NERD) and Control Patients 96
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 96
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 96
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 96
OS-078-YI Hepatic decompensation as an aetiology-dependent determinant of mortality in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab 95
A randomized phase II study assessing an optimized schedule of oregovomab (0) anti-CA1 25 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC) 94
Afatinib, an irreversible ErbB family inhibitor, demonstrates activity against HER2 mutated cervical cancer in vitro 94
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 93
706. DNA Vaccine Strategy Against Chronic B-Cell Lymphoma: Anti-Idiotypic CDR3 Vaccination 93
A Systematic Review of the Role of Lymphadenectomy in Pancreatic Cancer 92
Alimentazione e gravidanza fisiologica 92
Baccalaureate nursing students’ attitudes towards old people 92
66 ABERRANT GENES PROMOTER METHYLATION IN NEURAL-CREST DERIVED TUMOURS 92
35 DNA DOUBLE STRANDS BREAK REPAIR GENES EXPRESSION ANALYSIS REVEAL RAD51 AS A NEW POTENTIAL BIOMARKER IN BREAST CANCER. 92
Clinical outcomes and post-progression retreatment in patients with metastatic NSCLC who complete two years of treatment with immune checkpoint blockade 91
Amniotic membrane produces and releases nerve growth factor (NGF) and expresses NGF receptors 90
A New Technique for Laparoscopic Stripping of Endometriomas: FloSeal Hemostatic Agent for Hemostasis of the Ovarian Wall 90
Integrated treatment of pancreatic head carcinoma 89
Continent ileocolonic urinary diversion (rome pouch) for gynecologic malignancies: techniqueand feasibility. 89
45 GENE EXPRESSION OF SOMATOSTATIN RECEPTOR SUBTYPES SSTR2a, SSTR3 AND SSTR5 IN PERIPHERAL BLOOD OF NEUROENDOCRINE LUNG CANCER AFFECTED PATIENTS 89
5-YEAR ONCOLOGIC OUTCOMES FOR ROBOT-ASSISTED AND LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR HIGH-RISK RENAL TUMORS 89
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 89
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 88
ALT levels are associated with metabolic parameters and age in a large real-life population. 88
Drug releasing hybrid scaffold: new avenue in cardiovascular tissue engineering 86
Combined multimodality treatment of primary or recurrent locally advanced rectal cancer 83
"NO CLAMPING-NO SUTURING" LAPAROSCOPIC PARTIAL NEPHRECTOMY (LPN). 82
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 82
Adjuvant external and intraoperative radiation therapy in resectable pancreatic cancer 82
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 81
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 80
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 78
T.07.3: CHARACTERISTICS AND OUTCOMES OF IMMUNOTHERAPYRELATED LIVER INJURY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA COMPARED TO PATIENTS WITH ADVANCED SOLID TUMOURS 77
How long is the latent phase of labour? 68
Totale 14.180


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022708 0 0 11 6 57 8 6 3 24 32 13 548
2022/2023387 29 11 8 32 43 26 33 22 24 35 108 16
2023/20241.848 82 163 75 113 203 818 33 84 22 135 35 85
2024/202515.416 230 198 621 65 107 342 218 69 1.260 1.172 5.231 5.903
2025/20265.787 1.366 507 1.119 1.671 536 588 0 0 0 0 0 0
Totale 24.146